罗氏血凝仪CoaguChek XS在房颤抗凝管理体系中的应用
摘要
目的探讨CoaguChek XS血凝仪在房颤抗凝管理体系中的应用效果。方法对62例口服华法林的房颤患者分别应用血凝仪末梢血检测法和实验室静脉全血检测法检测国际标准化比值(INR),评价CoaguChek XS血凝仪测定INR值的准确性。结果62例患者末梢血检测INR平均值为(2.04±0.57),静脉全血INR平均值为(2.06±0.56),两种方法比较差异无统计学意义(t=0.911,P=0.366)。结论CoaguChek XS血凝仪有望在房颤抗凝管理体系中推广应用。
出处
《中华现代护理杂志》
2013年第6期693-694,共2页
Chinese Journal of Modern Nursing
参考文献10
-
1Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace,2010,12(10) : 1360-1420.
-
2王晓俏,陈样新.华法令抗凝治疗监测的相关问题探讨[J].临床内科杂志,2008,25(1):50-51. 被引量:8
-
3Wieloch M, Hillarp A, Strandberg K, et al. Comparison and evaluation of a point-of-care device ( CoaguChek XS) to Owren- type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin. Thromb Res,2009,124 ( 3 ) :344-348.
-
4Sobieraj-Teague M, Daniel D, Farrelly B, et al. Accuracy and clinical usefulness of the CoaguChek-S and XS point of care devices when starting warfarin in ahospital outreach setting. Thromb Res ,2009 ,123 ( 6 ) :909-913.
-
5Plesch W, Wolf T, Breitenbeek N, et al. Results of the performance verification of the CoaguChek XS system. Thromb Res,2008,123 (2) :381-389.
-
6Nam MH, Roh KH, Rak HN, et al. Evaluation of the Roche CoaguChek XS handheld coagulation analyzer in a cardiac outpatient clinic. Ann Clin Lab Sci,2008,38( 1 ) :37-40.
-
7Karon BS, Mc Bane RD, Chaudhry R, et al. Accuracy of capillary whole blood intemational normalized ratio on the CoaguChek S, CoaguChek XS,and i-STAT 1 pointof-care analyzers. Am J Clin Patho1.2008.130( 1 ) :88-92.
-
8杨进刚.心房颤动的诊断与药物治疗(中国专家共识)[J].心脑血管病防治,2008,8(4):215-222. 被引量:119
-
9吴晶,江蕾.临床护理路径在心房房颤华法林抗凝中的应用[J].中华现代护理杂志,2010,16(16):1892-1893. 被引量:6
-
10邹珺,吴华章,王书平,于然,韩春雷,柯青林,刘洁,范越.凝血PT/INR快速检测服务的卫生经济学评估[J].卫生软科学,2011,25(6):367-371. 被引量:2
二级参考文献18
-
1杨军,刘海燕,张真路,张李涛.CoaguChek XS国标标准化比值检测仪的临床应用[J].岭南心血管病杂志,2009,15(5):372-375. 被引量:4
-
2心房颤动抗栓研究协作组,胡大一,孙艺红,张鹤萍,姜立清.华法林对非瓣膜病心房颤动抗栓的安全性和有效性研究[J].中华内科杂志,2006,45(10):800-803. 被引量:64
-
3Denise Bockwoldt. Antithrombosis Management in Community-Dwelling Elderly: Improving Safety [J]. Geriatr Nars, 2010, (31):28-36.
-
4John R. Petersen, Hans M. Vonmarensdorf, Heidi L. Weiss, M Tarek Elghetany. Use of error grid analysis to evaluate acceptability of a point of care prothrombin time meter[J]. Clinica Chimica Acta, 2010, (411) :131-134.
-
5Ming Chai Kong, Teong Guan Lim, Heng Joo Ng, Yiong Huak Chan, Lai Heng Lee. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clicic[J]. Ann Hematol, 2008, (87) :905-910.
-
6Mattias Wieloch, Andreas Hillarp, Karin Strandberg, Camilla Nilsson, Peter J. Svensson. Comparison and evaluation of a Point-of-care device(CoaguChek XS)to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin[J].Thrombosis Research, 2009, (124):344-348.
-
7Karen Woods, James D. Douketis, Terri Schnurr, Krystyna Kinnon, Peter Powers, Mark A. Crowther. Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial [J]. Thrombosis Research, 2004, (114) : 161-165.
-
8Jennifer Elston Lafata, Susan A, Martin. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy[J]. Journal of General Internal Medicine, 2000, (15) :31-37.
-
9Hankey GJ. Non-valvular atrial fibrillation and stroke prevention[J]. Med J Aust, 2001, 174(5) : 234-239.
-
10Magdalena Sobieraj-Teague, Dolly Daniel, Barbara Farrelly, Douglas Coghlan, Alexander Gallus. Accuracy and clinical usefulness of the CoaguChek Sand XS Point of Care devices when starting warfarin in a hospital outreach setting[J].Thrombosis Research, 2009, (123): 909-913.
共引文献131
-
1吴传本.房颤采用厄贝沙坦治疗的临床效果分析[J].医学信息(医学与计算机应用),2014,0(24):568-568.
-
2黄健.抗凝小组在非瓣膜性房颤患者华法林治疗中的应用研究[J].医学信息(医学与计算机应用),2014,0(13):62-62.
-
3徐瑞,贠琳.口服抗凝药物预防心房颤动卒中的临床现状及进展[J].中华临床医师杂志(电子版),2012,6(24):7967-7970. 被引量:2
-
4牟丽君.抗凝药物在心房颤动治疗中的应用[J].中国医药指南,2009,7(11):82-83. 被引量:1
-
5陈炅,郭华,李艳华.氯沙坦和胺碘酮联用在心房颤动复律后维持窦性心律的作用[J].临床心血管病杂志,2009,25(8):633-634. 被引量:3
-
6蒙涛,马树人,田晓沂,杨静,于昆.华法林治疗非瓣膜病心力衰竭血栓形成的研究[J].中华内科杂志,2009,48(11):960-960. 被引量:1
-
7茹祥伟,丁丽丽.厄贝沙坦和胺碘酮联用在心房颤动复律后维持窦性心律的作用[J].中国现代药物应用,2010,4(3):115-116. 被引量:2
-
8李军,姜小飞,陈曦,石理,李朝晖.老年房颤患者华法林抗凝治疗社区管理与专科管理的对比研究[J].华西医学,2010,25(1):155-158. 被引量:7
-
9汪汝发,郑剑峰.心房颤动的药物治疗[J].中国社区医师(医学专业),2010,12(16):16-17. 被引量:2
-
10赵渊,杨松生,陈宗宁,杨利,文林,杨丽萍,陈耀武,魏引.丽江市心房颤动患者的治疗现状调查[J].中国医药指南,2010,8(17):148-150. 被引量:2
-
1邰文静.检测网织血小板对血小板减少性疾病的临床应用[J].国际检验医学杂志,2015,36(7):996-997. 被引量:4
-
2刘晓宇,王春燕,袁托亚,张迎军,阿荣,任保军.阿托伐他汀对急性冠脉综合征患者血浆NO Fg hsCRP水平的影响[J].内蒙古医学杂志,2009,41(10):1164-1166. 被引量:2
-
3姚东平.重症肝炎患者凝血功能检测分析[J].临床和实验医学杂志,2008,7(9):11-12. 被引量:4
-
4冯素清,孙巧英.三项生化指标对240例乙型肝炎预后判断的临床分析[J].内蒙古医学杂志,2005,37(10):893-894. 被引量:1
-
5孙雪松.采集末梢血检测HBsAg和HBsAb[J].临床输血与检验,2000,2(3):40-40. 被引量:1
-
6汤荣华,王玉萍.微量末梢血检测RF[J].皖南医学院学报,1995,14(3):318-318.
-
7秦帮才.末梢血糖化血红蛋白检测的临床应用[J].国际检验医学杂志,2014,35(6):778-779.
-
8杨举红.末梢血糖化血红蛋白检测的临床应用[J].中国实用医药,2014,9(19):16-17. 被引量:1
-
9乔薇,张小平,钱端,郑知刚.B型利钠肽在心力衰竭诊断和心功能评估中的临床价值[J].中日友好医院学报,2007,21(3):141-143. 被引量:8
-
10赵亮,罗以勤,孔建新,濮跃晨,马筱玲.急性心肌梗死患者血浆BNP、D-二聚体、纤维蛋白原水平变化与临床观察分析[J].安徽医药,2009,13(3):283-284. 被引量:13